Martingale Asset Management L P Regenxbio Inc. Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$16.46 - $19.99 $4,608 - $5,597
-280 Reduced 0.7%
39,950 $657,000
Q2 2023

Aug 11, 2023
SELL
$17.23 - $21.71 $6,892 - $8,684
-400 Reduced 0.98%
40,230 $804,000
Q1 2023

May 12, 2023
BUY
$18.08 - $24.55 $572,467 - $777,326
31,663 Added 353.11%
40,630 $768,000
Q4 2022

Feb 13, 2023
BUY
$20.4 - $24.73 $182,926 - $221,753
8,967 New
8,967 $203,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $339M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email